Cargando…

Circular RNA: a novel biomarker and therapeutic target for human cancers

Circular (circ)RNAs, a newly recognized class of noncoding RNA, have been implicated in the occurrence and development of several diseases, including neurological and cardiovascular diseases. Studies of human tumors, including those of liver cancer, gastric cancer, lung cancer and colorectal cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Bo, Tian, Zhiqiang, Fan, Weiping, Ni, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367529/
https://www.ncbi.nlm.nih.gov/pubmed/30745810
http://dx.doi.org/10.7150/ijms.28047
_version_ 1783393820906356736
author Lei, Bo
Tian, Zhiqiang
Fan, Weiping
Ni, Bing
author_facet Lei, Bo
Tian, Zhiqiang
Fan, Weiping
Ni, Bing
author_sort Lei, Bo
collection PubMed
description Circular (circ)RNAs, a newly recognized class of noncoding RNA, have been implicated in the occurrence and development of several diseases, including neurological and cardiovascular diseases. Studies of human tumors, including those of liver cancer, gastric cancer, lung cancer and colorectal cancer, have shown differential expression profiles of circRNAs, suggesting regulatory roles in cancer pathogenesis and metastasis. In this review, we discuss the most recent research into tumor-related circRNAs, providing a comprehensive summary of the expression or/and function of these circRNAs and proposing rational perspectives on the potential clinical application of circRNAs as helpful biomarkers or therapeutic targets in human tumors.
format Online
Article
Text
id pubmed-6367529
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-63675292019-02-11 Circular RNA: a novel biomarker and therapeutic target for human cancers Lei, Bo Tian, Zhiqiang Fan, Weiping Ni, Bing Int J Med Sci Review Circular (circ)RNAs, a newly recognized class of noncoding RNA, have been implicated in the occurrence and development of several diseases, including neurological and cardiovascular diseases. Studies of human tumors, including those of liver cancer, gastric cancer, lung cancer and colorectal cancer, have shown differential expression profiles of circRNAs, suggesting regulatory roles in cancer pathogenesis and metastasis. In this review, we discuss the most recent research into tumor-related circRNAs, providing a comprehensive summary of the expression or/and function of these circRNAs and proposing rational perspectives on the potential clinical application of circRNAs as helpful biomarkers or therapeutic targets in human tumors. Ivyspring International Publisher 2019-01-01 /pmc/articles/PMC6367529/ /pubmed/30745810 http://dx.doi.org/10.7150/ijms.28047 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Lei, Bo
Tian, Zhiqiang
Fan, Weiping
Ni, Bing
Circular RNA: a novel biomarker and therapeutic target for human cancers
title Circular RNA: a novel biomarker and therapeutic target for human cancers
title_full Circular RNA: a novel biomarker and therapeutic target for human cancers
title_fullStr Circular RNA: a novel biomarker and therapeutic target for human cancers
title_full_unstemmed Circular RNA: a novel biomarker and therapeutic target for human cancers
title_short Circular RNA: a novel biomarker and therapeutic target for human cancers
title_sort circular rna: a novel biomarker and therapeutic target for human cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367529/
https://www.ncbi.nlm.nih.gov/pubmed/30745810
http://dx.doi.org/10.7150/ijms.28047
work_keys_str_mv AT leibo circularrnaanovelbiomarkerandtherapeutictargetforhumancancers
AT tianzhiqiang circularrnaanovelbiomarkerandtherapeutictargetforhumancancers
AT fanweiping circularrnaanovelbiomarkerandtherapeutictargetforhumancancers
AT nibing circularrnaanovelbiomarkerandtherapeutictargetforhumancancers